Bolt Biotherapeutics Strategic Asset Allocation Index
Bolt Biotherapeutics strategic asset allocation index. Bolt Biotherapeutics (BOLT) has a Strategic Asset Allocation Index of 16.4% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $4.34 Million) total $4.34 Million, measured against net assets of $26.50 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Bolt Biotherapeutics balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Bolt Biotherapeutics (2021–2025)
Strategic asset allocation index of Bolt Biotherapeutics from 2021 to 2025. This chart shows how Bolt Biotherapeutics's Strategic Asset Allocation Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 16.4%, representing strategic assets of $4.34 Million against net assets of $26.50 Million USD. Check BOLT tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Bolt Biotherapeutics Strategic Asset Allocation Index by Year (2021–2025)
Bolt Biotherapeutics strategic asset allocation index by year from 2021 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Bolt Biotherapeutics from 2021 to 2025, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Bolt Biotherapeutics market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 16.4% | $4.34 Million | $- | $4.34 Million | $26.50 Million | ▼ -23.6 pp |
| 2024 | 40.0% | $22.88 Million | $- | $22.88 Million | $57.20 Million | ▲ +16.6 pp |
| 2023 | 23.4% | $26.41 Million | $- | $26.41 Million | $112.74 Million | ▼ -7.2 pp |
| 2022 | 30.6% | $52.47 Million | $28.52 Million | $23.94 Million | $171.51 Million | ▼ -15.8 pp |
| 2021 | 46.4% | $115.95 Million | $30.60 Million | $85.35 Million | $250.12 Million | — |